Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

New insights into the regulation of bile acids synthesis during the early stages of liver regeneration: A human and experimental study

  • Uriarte, Iker
  • Santamaría, Eva
  • López-Pascual, Amaya
  • Monte, María J.
  • Argemí, Josepmaria
  • Latasa, M. Ujue
  • Adán-Villaescusa, Elena
  • Irigaray, Ainara
  • Herranz, José M.
  • Arechederra, María
  • Basualdo, Jorge
  • Lucena, Felipe
  • Corrales, Fernando J.
  • Rotellar, Fernando
  • Pardo, Fernando
  • Merlen, Gregory
  • Rainteau, Dominique
  • Sangro, Bruno
  • Tordjmann, Thierry
  • Berasain, Carmen
  • Marín, José J. G.
  • Fernández-Barrena, Maite G.
  • Herrero, Ignacio
  • Avila, Matias A.
Background and aims: Liver regeneration is essential for the preservation of homeostasis and survival. Bile acids (BAs)-mediated signaling is necessary for liver regeneration, but BAs levels need to be carefully controlled to avoid hepatotoxicity. We studied the early response of the BAs-fibroblast growth factor 19 (FGF19) axis in healthy individuals undergoing hepatectomy for living donor liver transplant. We also evaluated BAs synthesis in mice upon partial hepatectomy (PH) and acute inflammation, focusing on the regulation of cytochrome-7A1 (CYP7A1), a key enzyme in BAs synthesis from cholesterol. Methods: Serum was obtained from twelve human liver donors. Mice underwent 2/3-PH or sham-operation. Acute inflammation was induced with bacterial lipopolysaccharide (LPS) in mice fed control or antoxidant-supplemented diets. BAs and 7α-hydroxy-4-cholesten-3-one (C4) levels were measured by HPLC-MS/MS; serum FGF19 by ELISA. Gene expression and protein levels were analyzed by RT-qPCR and western-blot. Results: Serum BAs levels increased after PH. In patients with more pronounced hypercholanemia, FGF19 concentrations transiently rose, while C4 levels (a readout of CYP7A1 activity) dropped 2 h post-resection in all cases. Serum BAs and C4 followed the same pattern in mice 1 h after PH, but C4 levels also dropped in sham-operated and LPS-treated animals, without marked changes in CYP7A1 protein levels. LPS-induced serum C4 decline was attenuated in mice fed an antioxidant-supplemented diet. Conclusions: In human liver regeneration FGF19 upregulation may constitute a protective response from BAs excess during liver regeneration. Our findings suggest the existence of post-translational mechanisms regulating CYP7A1 activity, and therefore BAs synthesis, independent from CYP7A1/Cyp7a1 gene transcription., This work was supported by grants from Ministerio de Ciencia, Innovación y Universidades MICINN-Agencia Estatal de Investigación integrado en el Plan Estatal de Investigación Científica y Técnica y Innovación, cofinanciado con Fondos FEDER PID2022-136616OB-I00 (MAA), PID2020-117116RB-I00 (MGFB), PID2021-127496NB-100 (FJC). Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Spain (PI14/01442 to FL and PI22/00526 to JJGM) co-funded by European Regional Development Fund/European Social Fund, “Investing in your future” (FL). Fundació Marato TV3 (Ref. 201916-31) (JJGM). INSERM and Agence National de la Recherche (ANR) grant 15-CE14-0007 (TT and GM). AECC post-doctoral fellowship POSTD18014AREC to MA. Ramón y Cajal Program contract RYC2018-024475-1 (MGFB) from the Spanish Ministry of Science and Innovation. Sara Borrell Contract CD22/00109 from the Spanish Ministry of Health (A.L-P.). AECC Undergraduate research fellowship PPLAB235506IRIG (A.I.). Grants from Fundación Mario Losantos and Fundación M Torres (MAA, CB, MGFB)., Peer reviewed
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Insulin-like Growth Factor I (IGF-I) expressed from an AAV1 vector leads to a complete reversion of liver cirrhosis in rats

  • Sobrevals, Luciano
  • Enguita Germán, Mónica
  • Quiroga, Jorge
  • Prieto, Jesús
  • Fortes, Puri
IGF-I modulates liver tissue homeostasis. It is produced by hepatocytes and signals within the liver through IGF-I receptor expressed on hepatic stellate cells (HSCs). Liver cirrhosis is characterized by marked IGF-I deficiency. Here we compared the effect of two different gene therapy vectors encoding IGF-I as a potential treatment for cirrhotic patients. Rats with carbon tetrachloride-induced liver cirrhosis were treated with controls or with adeno-associated virus 1 (AAV) or simian virus 40 (SV40) vectors expressing IGF-I (AAVIGF-I or SVIGF-I) and molecular and histological studies were performed at 4 days, 8 weeks and 16 weeks. Increased levels of IGF-I were observed in the liver as soon as 4 days after vector administration. Control cirrhotic rats showed increased hepatic expression of pro-inflammatory and pro-fibrogenic factors including transforming growth factor beta (TGFβ), tumor necrosis factor-alpha (TNFα), connective tissue growth factor (CTGF), and vascular endothelial growth factor (VEGF) together with upregulation of α-smooth muscle actin (αSMA), a marker of HSC activation. In IGF-I-treated rats the levels of all these molecules were similar to those of healthy controls by week 8 post-therapy. Of note, the decline of TGFβ, CTGF, VEGF and αSMA expression was more rapid in AAVIGF-I treated animals reaching statistical significance by day 4 post-therapy. IGF-I-treated rats showed similar improvement of liver function tests in parallel with upregulation of hepatocyte nuclear factor 4α (HNF4α), a factor that promotes hepatocellular differentiation. A significant decrease of liver fibrosis, accompanied by upregulation of the hepatoprotective and anti-fibrogenic hepatocyte growth factor (HGF), occurred in all IGF-I-treated rats but complete reversal of liver cirrhosis took place only in AAVIGF-I group. Therefore, AAVIGF-I reverts liver cirrhosis in rats, a capability which deserves clinical testing., This study was supported by grants from the Ministry of Science and Innovation (SAF2012-40003 and SAF2015-70971-R), CIBERehd and Fondo de Investigación Sanitaria (PI14/01442), financed by the Instituto de Salud Carlos III, Fundació La Marató de TV3 (20132132), Caja Navarra Foundation (70020), European FEDER funding and by the project RNAREG [CSD2009-00080], funded by the Ministry of Science and Innovation under the program CONSOLIDER INGENIO 2010.